Medicine and Dentistry
Esophageal Adenocarcinoma
100%
Patient
82%
Therapeutic Procedure
43%
Biological Marker
41%
Epidermal Growth Factor Receptor 2
26%
Protein
26%
Esophageal Cancer
25%
Prognosis
23%
Overall Survival
21%
Surgery
21%
Adenocarcinoma
21%
Chemotherapy
21%
Primary Tumor
15%
Chlordane
14%
Neoadjuvant Chemotherapy
14%
Chemoradiotherapy
12%
Plummer-Vinson Syndrome
12%
Colorectal Cancer
11%
Tumor Microenvironment
11%
Lymph Node Metastasis
11%
Stroma
10%
Hazard Ratio
10%
B Cell
10%
Capecitabine
10%
Adjuvant Chemotherapy
10%
Hypofractionated Radiotherapy
8%
Gemcitabine
8%
Interferon
8%
B Lymphocyte
8%
Monotherapy
8%
Learning
8%
Female
8%
Rectum Cancer
8%
Gastrectomy
8%
Cancer Therapy
8%
T Lymphocyte
8%
Pancreas Cancer
8%
Neoadjuvant Therapy
6%
Association
6%
Cancer Types
6%
Targeted Therapy
6%
Tissue Microarray
6%
Cells
5%
Immunology and Microbiology
Macrophage
26%
Density
19%
CD163
17%
B Cell
17%
CD68
17%
T Cell
17%
Immunocompetent Cell
16%
Programmed Death-Ligand 1
15%
Mismatch Repair
15%
CD8
13%
Prognostic Biomarker
8%
Lymphocyte Activation
8%
Matrix Protein
8%
Cartilage
8%
Tumor-Associated Macrophage
8%
Gamma Urogastrone
8%
Macrophage Subset
5%
